Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 4, 2003, Pages 1297-1300

  Miriagou, Vivi ^a   Tzouvelekis, Leonidas S ^b   Rossiter, Shannon ^c   Tzelepi, Eva ^a   Angulo, Frederick J ^c   Whichard, Jean M ^c  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM; CARBAPENEMASE KPC 2; CEFAMANDOLE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTAZIDIME PLUS CLAVULANIC ACID; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLAVULANIC ACID PLUS IMIPENEM; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CASE REPORT; DNA FLANKING REGION; GASTROENTERITIS; GENETIC CODE; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN STRUCTURE; SALMONELLA ENTERICA; SEQUENCE ANALYSIS; SEROTYPE; UNITED STATES;

BACTERIAL PROTEINS; BASE SEQUENCE; BETA-LACTAMASES; CLONING, MOLECULAR; CONJUGATION, GENETIC; DRUG RESISTANCE, BACTERIAL; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PLASMIDS; SALMONELLA;

EID: 0037379444     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.4.1297-1300.2003     Document Type: Article

References (24)

1. Bradford, P. A., Y. Yang, D. Sahm, I. Grop, D. Gardovska, and G. Storch. 1998. CTX-M5, a novel cefotaxime hydrolyzing β-lactamase from an outbreak of Salmonella typhimurium in Latvia. Antimicrob. Agents Chemother. 42:1980-1984.
2. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
3. Bush, K., and S. B. Singer. 1989. Effective cooling allows sonication to be used for liberation of β-lactamases from gram-negative bacteria. J. Antimicrob. Chemother. 24:82-84.
4. Fey, P., P. Safranek, M. E. Rupp, E. F. Dunne, E. Ribot, P. C. Iwen, P. A. Bradford, F. J. Angulo, and S. H. Hinrichs. 2000. Ceftriaxone-resistant Salmonella infection acquired by a child from cattle. N. Engl. J. Med. 342:1242-1249.
5. Giakkoupi, P., L. S. Tzouvelekis, A. Tsakris, V. Loukova, D. Sofianou, and E. Tzelepi. 2000. IBC-1, a novel integron-associated class A β-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain. Antimicrob. Agents Chemother. 44:2247-2253.
6. Lauf, U., C. Muller, and H. Herrmann. 1998. The transposable elements resident on the plasmids of Pseudomonas putida strain H, Tn5501 and Tn5502, are cryptic transposons of the Tn3 family. Mol. Gen. Genet. 259:674-678.
7. Matagne, A., J. Lamotte-Brasseur, and J.-M. Frere. 1998. Catalytic properties of class A β-lactamases: efficiency and diversity. Biochem. J. 330:581-598.
8. Morosini, M. I., R. Canton, J. Martinez-Beltran, M. C. Negri, J. C. Perez-Diaz, F. Baquero, and J. Blazquez. 1995. New extended-spectrum TEM-type β-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak. Antimicrob. Agents Chemother. 39:458-461.
9. Naas, T., L. Wandel, W. Sougakoff, D. M. Livermore, and P. Nordmann. 1994. Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A β-lactamase, Sme-1, from Serratia marcescens S6. Antimicrob. Agents Chemother. 38:1262-1270.
10. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A4 (M100-S7). National Committee for Clinical Laboratory Standards, Wayne, Pa.
11. National Committee for Clinical Laboratory Standards. 1997. Performance standards for antimicrobial disk susceptibility tests, 6th ed. Approved standard M2-A6 (M100-S7). National Committee for Clinical Laboratory Standards, Wayne, Pa.
12. Nordmann, P., S. Mariotte, T. Naas, R. Labia, and M.-H. Nicolas. 1993. Biochemical properties of a carbapenem-hydrolyzing β-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrob. Agents Chemother. 37:939-946.
13. Poupart, M. C., C. Chanal, D. Sirot, R. Labia, and J. Sirot. 1991. Identification of CTX-2, a novel cefotaximase from a Salmonella mbandaka isolate. Antimicrob. Agents Chemother. 35:1498-1500.
14. Raquet, X., J. Lamotte-Brasseur, F. Bouillenne, and J.-M. Frere. 1997. A disulfide bridge near the active site of carbapenem-hydrolyzing class A β-lactamases might explain their unusual substrate profile. Proteins 27:47-58.
15. Rasmussen, B. A., and K. Bush. 1997. Carbapenem-hydrolyzing β-lactamases. Antimicrob. Agents Chemother. 41:223-232.
16. Rasmussen, B. A., K. Bush, D. Keeney, Y. Yang, R. Hare, C. O'Gara, and A. A. Medeiros. 1996. Characterization of IMI-1 β-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrob. Agents Chemother. 40:2080-2086.
17. Revathi, G., K. P. Shannon, P. D. Stapleton, B. K. Jain, and G. L. French. 1998. An outbreak of extended-spectrum beta-lactamase-producing Salmonella senftenberg in a burns ward. J. Hosp. Infect. 40:295-302.
18. Sougakoff, W., T. Naas, P. Nordmann, E. Collatz, and V. Jarlier. 1999. Role of Ser-237 in the substrate specificity of the carbapenem-hydrolyzing class A β-lactamase Sme-1. Biochim. Biophys. Acta 1433:153-158.
19. Tassios, P. T., M. Gazouli, E. Tzelepi, H. Milch, N. Kozlova, S. V. Sidorenko, N. J. Legakis, and L. S. Tzouvelekis. 1999. Spread of a Salmonella typhimurium clone resistant to expanded-spectrum cephalosporins in three European countries. J. Clin. Microbiol. 37:3774-3777.
20. Vahaboglu, H., L. M. Hall, L. Mulazimoglu, S. Dodanli, I. Yildirim, and D. M. Livermore. 1995. Resistance to extended-spectrum cephalosporins, caused by PER-1 beta-lactamase, in Salmonella typhimurium from Istanbul, Turkey. J. Med. Microbiol. 43:294-299.
21. Villa, L., C. Pezzella, F. Tosini, P. Visca, A. Petrucca, and A. Carattoli. 2000. Multiple-antibiotic resistance mediated by structurally related IncL/M plasmids carrying an extended-spectrum β-lactamase gene and a class 1 integron. Antimicrob. Agents Chemother. 44:2911-2914.
22. Winokur, P. L., A. Brueggemann, D. L. DeSalvo, L. Hoffman, M. D. Apley, E. K. Uhlenhopp, M. A. Pfaller, and G. V. Doern. 2000. Animal and human multidrug-resistant, cephalosporin-resistant Salmonella isolates expressing a plasmid-mediated CMY-2 AmpC β-lactamase. Antimicrob. Agents Chemother. 44:2777-2783.
23. Winokur, P. L., D. L. Vonstein, L. J. Hoffman, E. K. Uhlenhopp, and G. V. Doern. 2001. Evidence for transfer of CMY-2 AmpC β-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrob. Agents Chemother. 45:2716-2722.
24. Yigit, H., A. M. Queenan, G. J. Anderson, A. Domenech-Sanchez, J. W. Biddle, C. D. Steward, S. Alberti, K. Bush, and F. C. Tenover. 2001. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:1151-1161.